Literature DB >> 14969425

Involvement of GABA(B) receptors in presynaptic inhibition of fibers of the descending projections of the spinal cord in the frog Rana ridibunda.

S V Ovsepyan1, N P Veselkin.   

Abstract

Isolated spinal cord preparations from Rana ridibunda frogs were used for studies of the effects of the GABA(B) receptor agonists (-)-baclofen (50 and 100 microM) and GABA (4-8 mM) and the specific GABA(B) receptor antagonist 2-hydroxysaclofen (100 microM) on the transmission of signals from fibers of the ventral columns monosynaptically connected with motoneurons in segments 9 and 10. These experiments showed that (-)-baclofen (50 and 100 microM) produced significant and dose-dependent suppression of excitatory postsynaptic potentials (EPSP) in motoneurons and ventral root potentials evoked by stimulation of fibers of the ipsi- and contralateral ventral columns. The inhibitory effect of (-)-baclofen (100 microM) on descending EPSP was 35-50% blocked by the GABA(B) receptor antagonist 2-hydroxysaclofen (0.2 mM). The inhibitory effect of GABA (4-8 mM) on descending EPSP was 60% blocked by the GABA(A) receptor antagonist picrotoxin (0.05 mM). (-)-Baclofen (50 microM) and GABA (4 and 6 mM) were found to have inhibitory effects on ventral root potentials evoked by stimulation of the ipsi- and contralateral ventral columns. The data obtained here, as well as data obtained by pharmacological analysis and conditioning by stimulation of the ipsi- and contralateral ventral columns, are regarded as a significant argument supporting the existence of GABA(B) receptor-mediated presynaptic inhibition of descending fibers connected monosynaptically to spinal cord motoneurons in the frog Rana ridibunda.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14969425     DOI: 10.1023/a:1025944704898

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  32 in total

1.  Shunting versus inactivation: analysis of presynaptic inhibitory mechanisms in primary afferents of the crayfish.

Authors:  D Cattaert; A El Manira
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

2.  The use of convulsants in studying possible functions of amino acids in the toad spinal cord.

Authors:  A K Tebecis; J W Phillis
Journal:  Comp Biochem Physiol       Date:  1969-03

3.  Inhibitory interaction between motoneurons of adjacent segments in the frog spinal cord.

Authors:  H S Meij; K C Holemans
Journal:  Exp Neurol       Date:  1969-02       Impact factor: 5.330

4.  gamma-Aminobutyric acid-induced depression of calcium currents of chick sensory neurons.

Authors:  R A Deisz; H D Lux
Journal:  Neurosci Lett       Date:  1985-05-14       Impact factor: 3.046

5.  [Afferent control of the effects of pyramidal impulses on spinal motoneurons].

Authors:  S M Sverdlov; E V Maksimova
Journal:  Fiziol Zh SSSR Im I M Sechenova       Date:  1966-05

6.  2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors.

Authors:  D I Kerr; J Ong; G A Johnston; J Abbenante; R H Prager
Journal:  Neurosci Lett       Date:  1988-09-23       Impact factor: 3.046

7.  Coexistence of GABAA and GABAB receptors on A delta and C primary afferents.

Authors:  M Désarmenien; P Feltz; G Occhipinti; F Santangelo; R Schlichter
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

8.  Tracing of frog sensory-motor synapses by intracellular injection of horseradish peroxidase.

Authors:  R Grantyn; A I Shapovalov; B I Shiriaev
Journal:  J Physiol       Date:  1984-04       Impact factor: 5.182

9.  GABAB receptor activation causes a depression of low- and high-voltage-activated Ca2+ currents, postinhibitory rebound, and postspike afterhyperpolarization in lamprey neurons.

Authors:  T Matsushima; J Tegnér; R H Hill; S Grillner
Journal:  J Neurophysiol       Date:  1993-12       Impact factor: 2.714

10.  Selective effects of (-)-baclofen on spinal synaptic transmission in the cat.

Authors:  D R Curtis; D Lodge; J C Bornstein; M J Peet
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.